DNA RNA and Cells
18 February 2015
Significant Findings in U.S. National Institutes of Health’s Trial of Pluristem’s PLX-R18 Cells for Treatment of Acute Radiation Syndrome17 February 2015
Cell Cure Neurosciences Ltd. Provides Update on its Product Development and Partnering Activities16 February 2015
IMPROVED SURVIVAL IN CHILDREN WITH GRAFT VERSUS HOST DISEASE WHO RESPOND TO MESOBLAST’S CELL THERAPY11 February 2015
Heat Biologics Presents Positive Preclinical Data on a Novel Approach to Combination Immunotherapy at the Keystone Symposia on Tumor Immunology10 February 2015
Enrollment Begins European Knee Meniscus Injury Pilot Trial to Evaluate Cytori Cell Therapy5 February 2015
Sangamo BioSciences Announces FDA Acceptance of IND to Initiate Clinical Trial of its Novel ZFP Therapeutic® for Beta-Thalassemia3 February 2015
Isis Pharmaceuticals Reports Data From Phase 2 Study of ISIS-PTP1B Rx in Patients With Type 2 Diabetes2 February 2015
Lion Biotechnologies Announces Allowance of IND Application to Begin New Phase 2 Study in Metastatic Melanoma2 February 2015
FDA Grants Breakthrough Therapy Designation to LentiGlobin for Treatment of Beta-Thalassemia Major29 January 2015
Vericel Completes Patient Enrollment in Phase 2b ixCELL-DCM Clinical Study of Ixmyelocel-T29 January 2015
Avita Medical Announces First Patient Enrollment in US Pivotal Study of ReCell(R) for the Treatment of Burns26 January 2015
BrainStorm Announces Exceptional Preclinical Results of NurOwn™ in Mouse Autism Model19 January 2015
Bone Therapeutics Demonstrates Efficacy in First Patient Cohort in ALLOB® Phase I/IIA Delayed-Union Trial17 January 2015
OncoGenex Announces Update on Phase 3 AFFINITY Trial Evaluating Custirsen in Men with Metastatic Castrate-Resistant Prostate Cancer14 January 2015
Sarepta Therapeutics Announces First Patient Dosed in European Phase I/II Study of SRP-4053 in Duchenne Muscular Dystrophy Patients12 January 2015
FDA Approves Cytori U.S. Pivotal Scleroderma Trial12 January 2015
FDA Approves Antria Phase 2 Stem Cell Clinical TrialsNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports